Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001513465 | SCV001721083 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001595081 | SCV001829582 | likely benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25257301) |
Ambry Genetics | RCV002564321 | SCV003718216 | likely benign | Inborn genetic diseases | 2022-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001513465 | SCV002087330 | likely benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2020-01-31 | no assertion criteria provided | clinical testing |